老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

51.55
-1.8400-3.45%
盘后：51.780.2300+0.45%18:19 EDT
成交量：110.41万
成交额：5,727.18万
市值：49.85亿
市盈率：-10.83
高：53.21
开：52.91
低：51.40
收：53.39
52周最高：78.00
52周最低：44.12
股本：9,669.26万
流通股本：9,316.62万
量比：0.53
换手率：1.19%
股息：- -
股息率：- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
净资产收益率：-26.09%
总资产收益率：-14.20%
市净率：2.85
市盈率(LYR):-7.97

数据加载中...

总览公司新闻资讯公告
2020/07/02

重要事件披露

8-K - Current report
2020/06/12

重要事件披露

8-K - Current report
2020/06/12

重要事件披露

8-K - Current report
2020/05/14

重要事件披露

8-K - Current report
2020/05/11

重要事件披露

Current report, items 7.01 and 9.01
2020/04/28

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/04/28

重要事件披露

Current report, items 2.02 and 9.01
2020/03/31

重要事件披露

Current report, item 8.01
2020/02/26

重要事件披露

8-K - Current report
2020/02/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/29

重要事件披露

Current report, item 5.02
2020/01/24

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/27

重要事件披露

Current report, items 1.02, 5.02, and 9.01
更多